Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Regents of the University of Colorado”

401 pharma patents match "The Regents of the University of Colorado" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 401
Index total 30,257
Page 8 / 17

Quick answer

This filtered view shows 401 pharmaceutical patents matching "The Regents of the University of Colorado" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

401 results for “The Regents of the University of Colorado” · 30,257 patents in full index Clear search

  1. US 10130604

    Composition and method for treating neurodegenerative disease

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  2. US 10117915

    Modulation of yeast-based immunotherapy products and responses

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  3. US 10111861

    Treatment of breast cancer

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  4. US 10080376

    Method for enhancing postprocessing content of beneficial compounds in beverages naturally containing same

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted

  5. US 10076520

    Use of tyrosine kinase inhibitor in cancer treatment

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted

  6. US 10052393

    Multifunctional nanomaterials for the treatment of cancer

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted

  7. US 10046036

    Chemically modified cystathionine β-synthase enzyme for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted

  8. US 9994901

    Pro-inflammatory mediators in diagnosis and treatment of chronic obstructive pulmonary disease

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted

  9. US 9980634

    Minimally-invasive measurement of esophageal inflammation

    The Regents of the University of Colorado, a Body Corporate · Granted May 29, 2018 · Expires May 24, 2038

    granted

  10. US 9949484

    Antimicrobial polyurethane materials and methods of forming and using same

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 24, 2018 · Expires Apr 19, 2038

    granted

  11. US 9950044

    Treatment of pulmonary vascular remodeling with neprilysin

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 24, 2018 · Expires Apr 19, 2038

    granted

  12. US 9949928

    Biodegradable copolymers, systems including the copolymers, and methods of forming and using same

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 24, 2018 · Expires Apr 19, 2038

    granted

  13. US 9938353

    Compositions, methods and uses for alpha-1 antitrypsin fusion molecules

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  14. US 9925162

    Methods and compositions for inducing physiological hypertrophy

    The Regents of the University of Colorado · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted

  15. US 9895420

    IL-1beta propeptide and IL-1Ra chimera and methods of using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 20, 2018 · Expires Feb 15, 2038

    granted

  16. US 9884096

    Compositions and methods related to graft versus host disease and treatments thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted

  17. US 9885018

    High efficiency reprogramming of fibroblasts into cardiomyocytes

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted

  18. US 9840520

    Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetylase-protein kinase inhibitors and methods of use thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted

  19. US 9820951

    Pulmonary disease treatment and diagnosis based on Arhgef1

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted

  20. US 9820957

    Methods of treating autoimmunity

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted

  21. US 9815890

    Antibodies to the C3d fragment of complement component 3

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted

  22. US 9796961

    Conditionally immortalized long-term stem cells and methods of making and using such cells

    The Regents of the University of Colorado · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted

  23. US 9775876

    Compositions and methods for CaMKII inhibitors and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 3, 2017 · Expires Sep 28, 2037

    granted

  24. US 9759731

    Disease severity index for assessment of chronic liver disease and method for diagnosis of three distinct subtypes of primary sclerosing cholangitis

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.